NEW YORK (GenomeWeb) – MDxHealth today reported that its fourth quarter revenues more than doubled year over year on a sharp rise in ConfirmMDx sales. 

The company said that total revenues increased to $3.4 million in the quarter, up from $1.6 million in Q4 2013. Revenues from the ConfirmMDx prostate cancer test rose to $2.4 million from $1.2 million as test volume increased 46 percent to more than 3,300 tests from 2,300 tests in the year-ago quarter. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.